Morgan Stanley analyst Stephen Byrd maintains Array Technologies (NASDAQ:ARRY) with a Equal-Weight and lowers the price target from $21 to $18.
Jefferies Maintains Buy on IGM Biosciences, Raises Price Target to $126
Jefferies analyst Chris Howerton maintains IGM Biosciences (NASDAQ:IGMS) with a Buy and raises the price target from $101 to $126.